October 2022

Congratulations to a CCBM Mentor, Kornelia Polyak, M.D., Ph.D. for her election to the prestigious National Academy of Medicine

Kornelia Polyak, M.D., Ph.D., professor of medicine, medical oncology, Dana-Farber Cancer Institute has been elected to the prestigious National Academy of Medicine. Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service. Read the full announcement here.

July 2022

Study Points to Link Between Genetic Ancestry and Genetic Signature of Lung Cancer

A study led by one of our mentors, Dr. Matthew Meyerson, discovered that genetic ancestry can influence molecular signatures of lung cancer. The analysis included lung cancer tissue from more than 1,100 patients in Mexico and Colombia, and was published in the March 2022 issue of Cancer Discovery. Read more here!

March 2022

Happy 75th Birthday Dana-Farber Cancer Institute!

Founded in 1947, Dana-Farber Cancer Institute, the home of our T32 Program, has been driving cancer care and transformative cancer research for 75 years now. The anniversary celebrations will continue throughout the year, and you can learn more about it here.

November 2021

Congratulations to our past trainees on their fellowships:

• Narek Darabedia, PhD – National Cancer Center Fellowship
• Laura Stevens, PhD – The Helen Gurley Brown Fellowship
• Kedar Puvar, PhD – NIH Postdoctoral Fellowship (F32)

November 16, 2021

CCBM Mentors among world’s most highly cited researchers

Institute for Scientific Information at Clarivate has recently released their list of Highly Cited Researchers. The criteria for inclusion into this list is that a researcher needs to produce multiple papers ranking in the top 1% by citations for their field and year of publication.

We congratulate our mentors who have been included on this prestigious list: Myles Brown, MD; Benjamin Ebert, MD, PhD; Pasi Jänne, MD; Matthew Meyerson, MD, PhD; Margaret Shipp, MD; Bruce M. Spiegelman, PhD and Catherine J. Wu, MD.

Read the full press release here.

October 19, 2021

In Memoriam: David Morse Livingston, MD, Renowned Scientist and Esteemed Mentor

Dana-Farber community and many others in the field of cancer research were saddened by the unexpected death of David Morse Livingston, MD. Read more about Dr. Livingston’s impact on the field and his legacy here.

September 23, 2021

Congratulations to CCBM Mentor, Cigall Kadoch, Ph.D. for her selection as a Howard Hughes Medical Institute Investigator

Cigall Kadoch, Ph.D. was named as a Howard Hughes Medical Institute (HHMI) Investigator. The HHMI Investigator Program is a prestigious and highly selective program that funds cutting-edge scientists as they pursue most pressing questions in biomedical research.

Read full announcement here!

July 09, 2021

Metabolomics Facility at Dana-Farber wins Massachusetts Life Sciences Center funding

Congratulations to our co-director, Dr. Nika Danial for winning a $1.82 million grant from the Massachusetts Life Sciences Center to build a new cutting-edge metabolomics facility at Dana-Farber Cancer Institute. The Center will help accelerate basic and translational discoveries in the field of cancer and other disease, such as obesity, diabetes, neurologic disorders and inborn errors of metabolism. Read more about Dr. Danial’s plans for the new metabolomics facility here.

March 20, 2021

Bruce M. Spiegelman, PhD, receives 2021 Albert Renold Award, a major mentorship award

Congratulations to one of our mentors, Dr. Bruce Spiegelman for being named the recipient of the 2021 Albert Renold Award. This award is presented to an individual whose career is distinguished by outstanding achievements in the training and mentorship of diabetes research scientists and in the development of communities of scientists to enhance diabetes research. Read more about Dr. Spiegelman’s mentoring philosophy here.